INTEGRA LIFESCIENCES HOLDINGS CORP Payments for (Proceeds from) Derivative Instrument, Investing Activities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Payments for (Proceeds from) Derivative Instrument, Investing Activities of $10.92 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for the quarter ending 2025-12-31 was $10.49M, a 154.08% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for the quarter ending 2024-12-31 was $4.13M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for the quarter ending 2023-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for the quarter ending 2023-09-30 was -$5.38M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for fiscal 2025 was $10.92M, a 164.54% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for fiscal 2024 was $4.13M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for fiscal 2023 was -$5.38M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for (proceeds from) derivative instrument, investing activities for fiscal 2022 was -$4.91M.
| Period end | Payments for (Proceeds from) Derivative Instrument, Investing Activities 3 month | Payments for (Proceeds from) Derivative Instrument, Investing Activities 6 month | Payments for (Proceeds from) Derivative Instrument, Investing Activities 9 month | Payments for (Proceeds from) Derivative Instrument, Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.92M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $432.00K 10-Q · filed 2025-10-30 | |||
| 2024-12-31 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.13M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.38M derived: sum of 2 quarters · filed 2026-02-26 | -$5.38M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$5.38M 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | -$4.91M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$4.91M 10-Q · filed 2023-10-25 | ||
| 2022-06-30 | -$4.91M 10-Q · filed 2023-07-27 | |||
| 2021-12-31 | -$76.00K 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $7.84M 10-K · filed 2023-02-22 | |||
| 2019-12-31 | -$1.58M 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |